DrugPatentWatch Database Preview
VEINAMINE 8% Drug Profile
see a sample report or, see our see our flat-rate plans
When do Veinamine 8% patents expire, and when can generic versions of Veinamine 8% launch?
The generic ingredient in VEINAMINE 8% is amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate. There are three hundred and forty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate profile page.
Summary for VEINAMINE 8%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | VEINAMINE 8% at DailyMed |
Pharmacology for VEINAMINE 8%
| Ingredient-type | Amino Acids |
| Drug Class | Amino Acid |
US Patents and Regulatory Information for VEINAMINE 8%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira Inc | VEINAMINE 8% | amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate | INJECTABLE;INJECTION | 017957-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
